USC study indicates periodic low-calorie diet could help patients with inflammatory bowel disease: A clinical trial shows reduction of inflammation.
USC researchers provided evidence that a low-calorie “fasting-mimicking” diet has the potential to do just that. Published in the Tuesday edition of Cell Reports, the study reports on the health benefits of periodic cycles of the diet for people with inflammation and indicated that the diet reversed inflammatory bowel disease (IBD) pathology in mice.
Results showed that fasting-mimicking diet caused a reduction in intestinal inflammation and an increase in intestinal stem cells in part by promoting the expansion of beneficial gut microbiota. Study authors say the reversal of IBD pathology in mice, together with its anti-inflammatory effects demonstrated in a human clinical trial, indicate that the regimen has the potential to mitigate IBD.
“This study for the first time combines two worlds of research,” said Valter Longo, a study author and the director of the USC Longevity Institute at the USC Leonard Davis School of Gerontology and professor of biological sciences at the USC Dornsife College of Letters, Arts and Sciences. “The first is about what you should eat every day, and many studies point to a diet rich in vegetables, nuts and olive oil. The second is fasting and its effects on inflammation, regeneration and aging.”
Fasting and IBD: Reducing inflammation
By combining these fields of research using the fasting-mimicking diet, the authors were able to reduce the inflammation and pathology associated with intestinal diseases.
Longo said for people with a poor diet, a “once in a while” fix is the periodic use of a low-calorie, plant-based diet that causes cells to act like the body is fasting. Earlier clinical trials conducted by Longo and colleagues allowed participants to consume between 750 and 1,100 calories per day over a five-day period and contained specific proportions of proteins, fats and carbohydrates. Participants saw reduced risk factors for many life-threatening diseases.
If you replace the fasting-mimicking diet …, with water, we don’t see the same benefits.
Valter Longo
“Fasting is hard to stick to and it can be dangerous,” Longo said. “We know that the fasting-mimicking diet is safer and easier than water-only fasting, but the big surprise from this study is that if you replace the fasting-mimicking diet, which includes pre-biotic ingredients, with water, we don’t see the same benefits.”
In the study, one group of mice adhered to a four-day fasting-mimicking diet by consuming approximately 50 percent of their normal caloric intake on the first day and 10 percent of their normal caloric intake from the second through fourth days. Another group fasted with a water-only diet for 48 hours.
The study demonstrated that two cycles of a four-day fasting-mimicking diet followed by a normal diet appeared to be enough to mitigate some, and reverse other, IBD-associated pathologies or symptoms. In contrast, water-only fasting came up short, indicating that certain nutrients in the fasting-mimicking diet contribute to the microbial and anti-inflammatory changes necessary to maximize the effects of the fasting regimen.
“We’ve determined that the dietary components are contributing to the beneficial effects; it’s not just about the cells of the human body but it’s also about the microbes that are affected by both the fasting and the diet,” Longo said. “The ingredients in the diet pushed the microbes to help the fasting maximize the benefits against IBD.”
The research team observed activation of stem cells and a regenerative effort in the colon and the small intestine, which increased significantly in length only in the presence of multiple cycles of the fasting-mimicking diet. They concluded that fasting primes the body for improvement, but it is the “re-feeding” that provides the opportunity to rebuild cells and tissues.
Fasting and IBD: Importance of “refeeding”
“It is really remarkable, that in the past 100 years of research into calorie restriction, no one recognized the importance of the re-feeding,” Longo said. “Restriction is like a demolition where you take the building down. But you have to rebuild it. If you don’t do that, there’s no benefit. You are left with an empty lot, and what have you achieved?”
In the current and previous studies, the authors showed that in patients with elevated C-reactive protein, a marker for inflammation, fasting-mimicking diet cycles are able to reduce C-reactive protein and reverse the associated increase in white blood cells. Together with the results in mice, these data indicate that fasting-mimicking diet cycles have the potential to be effective against human IBD, including Crohn’s disease and ulcerative colitis.
IBD afflicts an estimated 1.6 million Americans and is associated with acute and chronic inflammation of the intestine. Study authors say a randomized clinical trial involving the use of fasting-mimicking diet cycles to treat IBD is necessary to determine the safety and efficacy of these dietary treatments in humans, and are currently finalizing a clinical trial protocol.
Learn more: Fasting-mimicking diet holds promise for people with digestive problem
The Latest on: Inflammatory bowel disease
[google_news title=”” keyword=”inflammatory bowel disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Inflammatory bowel disease
- Take a step to find a cure to Chron’s disease and ulcerative colitison April 26, 2024 at 8:42 am
Join us at the Promenade at Sunset Walk to raise awareness and funds for those fighting and living with Crohn’s disease and ulcerative colitis (collectively known as inflammatory bowel disease or IBD) ...
- Global rise in the incidence of IBD a cause for concern, say expertson April 25, 2024 at 9:31 pm
The incidence of Inflammatory Bowel Disease has almost doubled in India from 1990 to 2019, with rising death rate; lifestyle changes, a Westernised diet with high fat and high sugar, processed and ...
- Fecal Transplant Shows Promise for Easing Inflammatory Bowel Disease Symptomson April 25, 2024 at 4:45 pm
For the study, scientists reviewed results from 15 clinical trials that tested fecal microbiota transplants (FMT) — when stool with healthy microorganisms is inserted into a sick patient’s digestive ...
- Medical Moment: The accidental discovery to treat inflammatory bowel diseaseon April 25, 2024 at 2:50 pm
There’s new hope after that same brain enzyme was found in the gut during IBD flareups, opening the door to tackle neuro and gut disease through a simple pill.
- What is Auto-Brewery Syndrome? Rare Disease That Converts Carbohydrate Into Alcohol In Human Bodieson April 24, 2024 at 9:08 pm
A Belgian man who was recently charged with drunk-driving has been acquitted. This is because he suffers from a rare disorder in which the body converts carbohydrates into ethanol, or ethyl alcohol.
- Scientists discover the cellular functions of a family of proteins integral to inflammatory diseaseson April 24, 2024 at 1:49 pm
In a scientific breakthrough, researchers have revealed the biological mechanisms by which a family of proteins known as histone deacetylases (HDACs) activate immune system cells linked to ...
- Health Beat: The accidental discovery to treat IBDon April 24, 2024 at 1:00 pm
There is new hope after that same brain enzyme was found in the gut during IBD flareups, opening the door to tackle neuro and gut disease through a simple pill.
- What You Need To Know about Crohn's Disease Poopon April 24, 2024 at 2:30 am
Crohn's disease can affect the appearance and smell of your poop. It can also cause changes in your bowel movements, like how often you need to poop.
- Gut bacteria and inflammatory bowel disease: Exploring the potential of prebioticson April 22, 2024 at 1:38 pm
A growing body of research suggests that manipulating gut bacteria may offer a promising approach to managing inflammatory bowel disease (IBD), a chronic and debilitating condition affecting millions ...
- Loss of Anti-TNF Treatment Response Common in Crohn's Diseaseon April 22, 2024 at 1:08 pm
Approximately two-thirds of patients with Crohn's disease who initially responded to tumor necrosis factor (TNF) inhibitors lost response by the third year of treatment, a population-based ...
via Bing News